Market Cap | 84.10B | P/E | 41.27 | EPS this Y | 9.40% | Ern Qtrly Grth | -7.00% |
Income | 2.34B | Forward P/E | 29.98 | EPS next Y | 10.80% | 50D Avg Chg | 6.00% |
Sales | 8.92B | PEG | 3.49 | EPS past 5Y | 10.02% | 200D Avg Chg | 11.00% |
Dividend | 1.00% | Price/Book | 18.73 | EPS next 5Y | 9.57% | 52W High Chg | -7.00% |
Recommedations | 1.90 | Quick Ratio | 1.65 | Shares Outstanding | 453.05M | 52W Low Chg | 47.00% |
Insider Own | 0.20% | ROA | 14.41% | Shares Float | 452.25M | Beta | 0.88 |
Inst Own | 95.88% | ROE | 48.89% | Shares Shorted/Prior | 5.04M/4.06M | Price | 182.00 |
Gross Margin | 70.01% | Profit Margin | 26.29% | Avg. Volume | 2,093,556 | Target Price | 217.58 |
Oper. Margin | 38.37% | Earnings Date | Nov 4 | Volume | 2,074,218 | Change | -1.89% |
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
Stifel | Buy | Sep 18, 24 |
Stifel | Buy | Aug 27, 24 |
Piper Sandler | Overweight | Aug 14, 24 |
BTIG | Buy | Aug 12, 24 |
Stifel | Buy | Aug 5, 24 |
BTIG | Buy | Jul 25, 24 |
HSBC | Buy | May 8, 24 |
Goldman Sachs | Buy | May 6, 24 |
Stifel | Buy | Apr 30, 24 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Lagano Roxanne | Executive Vice Presi.. Executive Vice President | Jan 18 | Sell | 191.43 | 923 | 176,690 | 17,569 | 01/19/24 |
Lagano Roxanne | Executive Vice Presi.. Executive Vice President | Dec 14 | Sell | 200 | 2,500 | 500,000 | 19,415 | 12/14/23 |
Lagano Roxanne | Executive Vice Presi.. Executive Vice President | Sep 01 | Sell | 192.97 | 923 | 178,111 | 25,434 | 09/05/23 |
Lagano Roxanne | Executive Vice Presi.. Executive Vice President | Apr 18 | Sell | 175.94 | 4,338 | 763,228 | 26,357 | 04/19/23 |
Lagano Roxanne | Executive Vice Presi.. Executive Vice President | Apr 18 | Option | 80.38 | 4,338 | 348,688 | 30,695 | 04/19/23 |
Lagano Roxanne | Executive Vice Presi.. Executive Vice President | Jul 22 | Option | 80.38 | 2,167 | 174,183 | 25,854 | 07/26/22 |
Lagano Roxanne | Executive Vice Presi.. Executive Vice President | Jul 22 | Sell | 180.26 | 2,167 | 390,623 | 23,687 | 07/26/22 |
Lagano Roxanne | Executive Vice Presi.. Executive Vice President | Jun 27 | Option | 80.38 | 4,334 | 348,367 | 28,021 | 06/28/22 |
Lagano Roxanne | Executive Vice Presi.. Executive Vice President | Jun 27 | Sell | 175 | 4,334 | 758,450 | 23,687 | 06/28/22 |
Reed Willie M | Director Director | Jun 10 | Sell | 162.31 | 1,855 | 301,085 | 6,782 | 06/13/22 |
Lagano Roxanne | Executive Vice Presi.. Executive Vice President | Apr 26 | Option | 80.38 | 2,167 | 174,183 | 25,854 | 04/28/22 |
Lagano Roxanne | Executive Vice Presi.. Executive Vice President | Apr 26 | Sell | 178.96 | 2,167 | 387,806 | 23,687 | 04/28/22 |
PECK KRISTIN C | Chief Executive Offi.. Chief Executive Officer | Feb 25 | Option | 30.89 | 10,000 | 308,900 | 49,743 | 02/28/22 |
PECK KRISTIN C | Chief Executive Offi.. Chief Executive Officer | Feb 25 | Sell | 192.25 | 10,000 | 1,922,500 | 39,743 | 02/28/22 |
David Glenn | Executive Vice Presi.. Executive Vice President | Feb 23 | Option | 66.8 | 32,390 | 2,163,652 | 78,962 | 02/24/22 |
David Glenn | Executive Vice Presi.. Executive Vice President | Feb 23 | Sell | 189.87 | 32,390 | 6,149,889 | 46,572 | 02/24/22 |
Lagano Roxanne | Executive Vice Presi.. Executive Vice President | Feb 15 | Sell | 196.54 | 2,065 | 405,855 | 23,687 | 02/16/22 |
Chen Heidi C. | Executive Vice Presi.. Executive Vice President | Nov 09 | Option | 73.24 | 9,446 | 691,825 | 33,541 | 11/10/21 |
Chen Heidi C. | Executive Vice Presi.. Executive Vice President | Nov 09 | Sell | 220 | 9,446 | 2,078,120 | 24,095 | 11/10/21 |
Chen Heidi C. | Executive Vice Presi.. Executive Vice President | Oct 25 | Option | 73.24 | 9,446 | 691,825 | 33,541 | 10/26/21 |
Chen Heidi C. | Executive Vice Presi.. Executive Vice President | Oct 25 | Sell | 210.22 | 9,446 | 1,985,738 | 24,095 | 10/26/21 |
Lagano Roxanne | Executive Vice Presi.. Executive Vice President | Aug 24 | Sell | 207.02 | 9,603 | 1,988,013 | 22,874 | 08/24/21 |
SCULLY ROBERT W | Director Director | Feb 23 | Buy | 164.72 | 7,590 | 1,250,225 | 7,590 | 02/23/21 |
Alaix Juan Ramon | Director Director | Feb 23 | Option | 73.24 | 133,070 | 9,746,047 | 347,377 | 02/23/21 |
Alaix Juan Ramon | Director Director | Feb 23 | Sell | 160.94 | 133,070 | 21,416,286 | 214,307 | 02/23/21 |
Trawicki Roman | Executive Vice Presi.. Executive Vice President | Feb 18 | Option | 73.24 | 3,285 | 240,593 | 8,114 | 02/18/21 |
Trawicki Roman | Executive Vice Presi.. Executive Vice President | Feb 18 | Sell | 165.82 | 4,491 | 744,698 | 3,623 | 02/18/21 |
PECK KRISTIN C | Chief Executive Offi.. Chief Executive Officer | Nov 25 | Option | 30.89 | 6,500 | 200,785 | 38,374 | 11/25/20 |
PECK KRISTIN C | Chief Executive Offi.. Chief Executive Officer | Nov 25 | Sell | 161.72 | 10,500 | 1,698,060 | 27,874 | 11/25/20 |
Lagano Roxanne | Executive Vice Presi.. Executive Vice President | Nov 20 | Option | 41.83 | 6,000 | 250,980 | 41,680 | 11/20/20 |
Trawicki Roman | Executive Vice Presi.. Executive Vice President | Oct 02 | Option | 55.02 | 4,080 | 224,482 | 5,501 | 10/02/20 |
Trawicki Roman | Executive Vice Presi.. Executive Vice President | Oct 02 | Sell | 165.65 | 5,501 | 911,241 | 10/02/20 |